Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group

FieldValue
dc.contributor.authorThabane, Lehana
dc.contributor.authorWells, George
dc.contributor.authorCook, Richard
dc.contributor.authorPlatt, Robert
dc.contributor.authorPogue, Janice
dc.contributor.authorPullenayegum, Eleanor
dc.contributor.authorMatthews, David
dc.contributor.authorMcCready, Tara
dc.contributor.authorDevereaux, Philip J
dc.contributor.authorCairns, John A
dc.contributor.authorYusuf, Salim
dc.date.accessioned2015-12-18T10:56:41Z
dc.date.available2015-12-18T10:56:41Z
dc.date.issued2011-02-18
dc.identifier.citationTrials. 2011 Feb 18;12(1):48
dc.identifier.urihttp://dx.doi.org/10.1186/1745-6215-12-48
dc.identifier.urihttp://hdl.handle.net/10393/33822
dc.description.abstractAbstract The Biostatistics and Methodological Innovation Working (BMIW) Group is one of several working groups within the CANadian Network and Centre for Trials INternationally (CANNeCTIN). This programme received funding from the Canadian Institutes of Health Research and the Canada Foundation for Innovation beginning in 2008, to enhance the infrastructure and build capacity for large Canadian-led clinical trials in cardiovascular diseases (CVD) and diabetes mellitus (DM). The overall aims of the BMIW Group's programme within CANNeCTIN, are to advance biostatistical and methodological research, and to build biostatistical capacity in CVD and DM. Our program of research and training includes: monthly videoconferences on topical biostatistical and methodological issues in CVD/DM clinical studies; providing presentations on methods issues at the annual CANNeCTIN meetings; collaborating with clinician investigators on their studies; training young statisticians in biostatistics and methods in CVD/DM trials and organizing annual symposiums on topical methodological issues. We are focused on the development of new biostatistical methods and the recruitment and training of highly qualified personnel - who will become leaders in the design and analysis of CVD/DM trials. The ultimate goal is to enhance global health by contributing to efforts to reduce the burden of CVD and DM.
dc.titleCanadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group
dc.typeJournal Article
dc.date.updated2015-12-18T10:56:41Z
dc.language.rfc3066en
dc.rights.holderThabane et al; licensee BioMed Central Ltd.
CollectionLibre accès - Publications // Open Access - Publications

Files